Showing results (531-540 of 724) with videos related to
Sort By:
Pageof 73
Breast Cancer Research and Treatment|July 4, 2024
Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective studyFrancesca Magnoni, Beatrice Bianchi, Eleonora Pagan, et al.Medicina (Kaunas, Lithuania)|January 8, 2025
Establishing an Extracorporeal Cardiopulmonary Resuscitation ProgramPietro Bertini, Fabio Sangalli, Paolo Meani, et al.Anti-Cancer Drugs|August 18, 2021
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patientsEmilia Montagna, Eleonora Pagan, Giuseppe Cancello, et al.Eclinicalmedicine|March 28, 2024
Comparison of long-term outcome between clinically high risk lobular versus ductal breast cancer: a propensity score matched studyFrancesca Magnoni, Giovanni Corso, Patrick Maisonneuve, et al.Journal of Alzheimer'S Disease : JAD|September 11, 2023
Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: Case Report and Review of the LiteratureFederico Verde, Edoardo Nicolò Aiello, Laura Adobbati, et al.Cancer|July 15, 2023
Pathological and radiological response following neoadjuvant treatments in primary localized resectable myxofibrosarcoma and undifferentiated pleomorphic sarcoma of the extremities and trunk wallMaria Danieli, Francesco Barretta, Stefano Radaelli, et al.Reproductive Biomedicine Online|January 4, 2011
Ooplast-mediated developmental rescue of bovine oocytes exposed to ethidium bromideMarcos Roberto Chiaratti, Christina Ramires Ferreira, Felipe Perecin, et al.Transplantation|September 14, 2006
Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantationCornelio Uderzo, Sonia Bonanomi, Alessandro Busca, et al.The Oncologist|January 11, 2026
Real-world patterns of post-progression treatment and outcomes in patients with HR+/HER2- advanced breast cancer treated with CDK4/6 inhibitorsRosalba Torrisi, Federica Giugliano, Laura Giordano, et al.Expert Opinion on Drug Delivery|March 1, 2016
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER studyDamiano Paolicelli, Eleonora Cocco, Valentina Di Lecce, et al.Pageof 73